The viability of a programme for delivering aerosolized pentamidine within the patient's home setting for the secondary prophylaxis of Pneumocystis carinii pneumonia (PCP) has been explored with seven homosexual AIDS patients, the major objectives being the assessment of the safety and acceptability of the treatment and the discovery of the most suitable care setting (home, ward, outpatient clinic) for the administration of therapy. It is concluded that a domiciliary prophylaxis programme is a viable alternative.
ConteJ.E., HollanderH., GoldenJ.A.Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia.Ann Intern Med1987; 107: 495–8
2.
MontgomeryA.B., DebsR.J., LuceJ.M.. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immune deficiency syndrome.Lancet1987; ii: 480–3
3.
ConteJ.E., ChernoffD., HollanderH.H., GoldenJ.Once monthly inhaled pentamidine for the prevention of Pneumocystis carinii pneumonia (PCP). IVth International Conference on AIDS, Stockholm, June 1988; abstract 7165
4.
O'DohertyM.J., PageC., BradbeerC., ThomasS., BarlowD., NunanT., BatemanN.T.Differences in relative efficiency of nebulisers for pentamidine administration.Lancet1988; ii: 1283–6
5.
SmithD.E., HerdD.A., HawkinsD.A., GazzardB.G.Pneumocystis carinii pneumonia prophylaxis with inhaled pentamidine. IVth International Conference on AIDS, Stockholm, June 1988; abstract 7164
6.
GabinS.J., PoscherH.L.Nebulised pentamidine for prophylaxis of Pneumocystis carinii pneumonia. IVth International Conference on AIDS, Stockholm, June 1988; abstract 7168
